当前位置: 首页 > 期刊 > 《中国医学创新》 > 2024年第4期
编号:1848106
育龄期女性多囊卵巢综合征的治疗研究进展
http://www.100md.com 2024年4月4日 中国医学创新 2024年第4期
     陈莉 马耀华

    【摘要】 多囊卵巢综合征(PCOS)是一种临床常见的生殖内分泌紊乱性疾病,临床表现呈现高度异质性,发病机制复杂且不明确,有关PCOS的治疗尚无统一的标准。目前,临床主要采用对症治疗的方式来调节PCOS女性的月经周期,改善胰岛素抵抗(IR),降低雄激素水平等。对症治疗的方式主要包括西医治疗、中医治疗及中西医结合治疗,且每种治疗方式都在不断地更新和完善。基于此,本论文就PCOS近年来的治疗及治疗新进展做一总结,以期为临床进一步规范治疗PCOS提供一定的参考依据。

    【关键词】 多囊卵巢综合征 高雄激素血症 胰岛素抵抗

    Research Progress on the Treatment of Female Polycystic Ovary Syndrome in Childbearing Age/CHEN Li, MA Yaohua. //Medical Innovation of China, 2024, 21(04): -155

    [Abstract] Polycystic ovary syndrome (PCOS) is a common clinical reproductive endocrine disorders disease, its clinical manifestations exhibiting high heterogeneity, the pathogenesis is complex and unclear, and there is not uniform standard for the treatment of PCOS. At present, symptomatic treatment is mainly used to regulate the menstrual cycle in clinical, improve insulin resistance (IR), and reduce androgen levels in women with PCOS. Symptomatic treatment mainly including western medicine treatment, traditional Chinese medicine treatment, and integrating Chinese and western medicine, each treatment method is constantly updating and improving. Based on it ......

您现在查看是摘要页,全文长 14897 字符